Maichuan (Guangzhou) Biotechnology Co., Ltd., an incubated startup from the "Bio-Island Laboratory," leverages the national laboratory's technology platform and has assembled a strong core technology team comprised of graduate students and postdoctoral fellows from the Chinese Academy of Sciences and renowned universities. The company focuses on the R&D, production, and sales of core raw materials for in vitro diagnostics. Maichuan is committed to establishing a high-quality core raw material platform, providing high-quality antigen and antibody raw materials, and overcoming the "bottleneck" problems in the IVD industry. Currently, it has independently developed and launched in vitro diagnostic raw materials for cytokines, autoimmune diseases, neurodegenerative diseases, and tumor markers, suitable for chemiluminescence, ELISA, flow cytometry, and other technology platforms. Its products have been widely used by over a hundred IVD companies and have gained significant recognition.